Saladax Biomedical, Inc.

Complete development of a novel immunoassay for the chemotherapy drug, 5-fluorouracil. This is the most commonly used agent for the treatment of colorectal, breast, and head and neck cancers. Like the other chemotherapy monitoring assays in Saladax’s product line, this “Personalized Chemotherapy Monitoring” test will help oncologists adjust chemotherapy drug dosing by measuring its concentration in the blood of cancer patients. Individual absorption rates of chemotherapy drugs vary widely, and the optimum level of medication is critical to effectively treat the cancer while minimizing debilitating and potentially life-threatening side effects.